Molecular Medicine Ireland is a not-for-profit research partnership established in 2008 by the NUI Galway, Royal College of Surgeons in Ireland, Trinity College Dublin, University College Cork and University College Dublin, their associated academic hospitals and clinical research facilities, to accelerate the translation of biomedical research into improved diagnostics, therapies and devices for patients.
Molecular Medicine Ireland builds on the achievements of the Dublin Molecular Medicine Centre (DMMC) formed by University College Dublin and Trinity College in 2002, The Royal College of Surgeons in Ireland joined the partnership in 2005, and in 2008 it became an all-Ireland entity with the accession of NUI Galway and University College Cork.
Since 2002, MMI and its partner institutions have succeeded in winning substantial funding from Enterprise Ireland, EU FP6 & 7, Higher Education Authority PRTLI cycles 1-5, Health Research Board, Health Service Executive, Irish Cancer Society/Movember, Science Foundation Ireland and the Wellcome Trust, for cross-institutional initiatives, such as, the Clinician Scientist Fellowship Programme and Clinical and Translational Research Scholars PhD programmes, Irish Clinical Research Infrastructure Network, Dublin Centre for Clinical Research, iPROSPECT and IPCOR prostate cancer research programmes, HRB Clinical Research Co-ordination Ireland and CURAM, the SFI Centre for Research in Medical Devices.
MMI’s strategic vision is to improve healthcare through the development of diagnostics and therapies from concept to realisation.
MMI’s mission is to mobilise the strengths of the five partner institutions and their associated hospitals to build a sustainable national system to coordinate, support and promote translational and clinical research.
- To connect the key players in health, research and industry
- To attract, train and retain world class researchers
- To work towards the provision of state-of-the-art facilities, bio-resources and harmonised processes
- To represent Ireland in clinical and translational research infrastructures/networks in Europe and internationally
- To build collaborative research initiatives and opportunities.